20/20 Capital Management »

SPDR S&P Biotech shares owned by 20/20 Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by 20/20 Capital Management from 13F filings

Historical chart of 20/20 Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by 20/20 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by 20/20 Capital Management

Quarter filed Position value Share count Share price at filing
2021-06-30 $537k 4.0k 135.30
2021-03-31 $465k 3.4k 135.77
2020-12-31 $521k 3.2k 163.32

More positions owned by 20/20 Capital Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Specialized Funds Div App Etf (VIG)
Proshares Tr S&p 500 Dv Arist (NOBL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Blackrock Science & Technolo SHS (BST)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
J P Morgan Exchange-traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vaneck Vectors Etf Tr Pharmaceutical (PPH)
J P Morgan Exchange-traded F Intl Bd Opp Etf (JPIB)
Wisdomtree Tr Emer Mkt High Fd (DEM)
Apple (AAPL)

View all positions for 20/20 Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Millennium Management
Citadel Advisors
Susquehanna International
PEAK6 Investments
UBS Group
NWI Management
Bnp Paribas Arbitrage, Snc
Parallax Volatility Advisers
Wells Fargo & Company

View all funds holding SPDR S&P Biotech